Skip to main content

Table 2 Clinical, laboratory, echocardiographic and catheter criteria in different types of CHD

From: Angiogenic biomarkers in children with congenital heart disease: possible implications

Patients groups C-CHD (n = 30) A-CHD (n = 30)
Studied
Parameters
   TOF
(n = 14)
TGA
(n = 9)
DORV
(n = 7)
VSD
(n = 11)
PS
(n = 8)
Aortic coarct
(n = 5)
PDA
(n = 3)
ASD
(n = 3)
Heart failure (n = 18/60) 4 5 3 5 - 1 - -
Cardiomegaly (n = 25/60) 4 4 4 7 - 1 3 2
SpO2 (%) 83 ± 3.6 80 ± 2.1 82.6 ± 5.4 97 ± 1.3 96 ± 2.2 96.2 ± 3.1 97.1 ± 4.8 94 ± 3.5
Hemoglobin (g./dl) 15 ± 3.3 16.2 ± 2 16.9 ± 4.3 10.5 ± 2 10 ± 3.2 10.4 ± 3.6 11.9 ± 1.8 10.8 ± 0.9
PH (n = 12/60) - 5 3 4 - - - -
Severe PS (n = 21/60) 11 2 3 - 5 - - -
Collaterals by echo (n = 11/60) 5 1 1 - 2 2 - -
Collaterals by catheter (n = 8/19) 6 Not done Not done - Not done 2 Not done Not done